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A laboratorian’s experience of 
implementing multiple point-of-
care testing in HIV antiretroviral 
treatment clinics in South Africa
To the Editor: Point-of-care testing (POCT) is a top agenda item 
for healthcare providers. What, where, when and how to implement 
it is under investigation, and a current focus of my research: ‘To 
determine the feasibility of implementing multiple POCT in clinics 
for HIV ART initiation’.
I left the safe laboratory environment where anonymous 
specimens were tested within a rigid quality structure, governed 
by a framework of good clinical laboratory practice principles 
(GCLP),[1] and entered the clinic environment of smiling faces, cute 
children and what appeared to me to be total chaos. The SEAD 
report[2] was not encouraging, but I took the plunge and went on a 
road trip with my team.
We visited 12 clinics in Gauteng, North-West and Free State 
Provinces, and just the poor road infrastructure in many places was 
realisation enough of the difficulties that patients and laboratory 
specimen couriers face. There was great variation across clinics, in 
terms of suitable space for POCT testing; all sites required some 
renovation that ranged from installing a bench and security gate, 
to erecting pre-fabricated structures. All clinic staff welcomed our 
presence. Not one refused the idea of POCT, but all claimed that 
they had no time to perform POCT and that this function would 
require a dedicated ‘lab person’. Our research showed that performing 
multiple POCT (CD4, Hb, ALT, creatinine, lactate and TB GeneXpert 
(Cepheid, Sunnyvale, CA)) requires about 22 additional tasks. 
Removing a nurse from her current NIMART[3] duties for POCT 
seems extreme and costly. We showed that counsellors easily 
performed POCT. However, in South Africa (owing to HPCSA, 
SANAS, etc. regulations), these personnel are currently unable to 
perform phlebotomies. ‘Ah, don’t worry, all the POCT we needed 
could be performed on finger-stick’. Problem solved … or is it? For 
implementing these numerous POCTs means that patients require 
>3 finger-stick procedures/visit after HIV counselling and testing 
(HCT). We obtained ethics approval to perform several finger-stick 
procedures on patients. To our surprise, all patients preferred finger-
sticks over venepuncture. We remain cautious because research 
shows that performing CD4 cell-based assays with capillary testing 
(such as PIMA (Alere Healthcare)) increased variability[4] and was 
associated with high error rates.
Can nurses perform multiple POCT and be trained in GCLP? 
The answer is ‘Yes’, but there are issues concerning computer 
literacy for using GeneXpert. The other issue with computers 
is secure data recording. The IT engineer who travelled with us 
reminded us constantly that, without connectivity, we would not be 
able to manage POCT data. This means that without a ‘laboratory 
information system’ (LIS) through which the National Health 
Laboratory Service (NHLS) links their testing platforms to a central 
data warehouse, POCT results would not be collected. Even if we 
did have a connectivity solution, several POCT platforms would 
not be able to connect.
Another hurdle for POCT is throughput: Clinic staff told us that 
the ‘magic patient number for ART initiation/day’ is 5, which fits 
with POCTs, but many more would have to be tested each day to 
select those 5.
One aspect I had not appreciated was that clinics were less busy, 
or even empty, in the afternoons. This seemed great for clinic staff 
and patients, but a shame for the POCTs that are especially time-
consuming: Each PIMA CD4 test takes 20 minutes; but adding 3 
other POCTs takes >1 hour. Not to mention the GeneXpert test at 
POC: If the clinic has a Gx4, 4 results take about 2½ hours; so if you 
are the 5th patient, it takes 5 hours for a result. One of our studies 
also showed that successful use of GeneXpert requires 2½ personnel 
to ensure that 15 patients receive same-day treatment.[5]
Sadly, we also experienced high clinic staff turnover, HCT kit 
shortages, the occasional clinic where ART initiation was only 
conducted once per week, and the usual unstable power supply. All 
contribute to disruption of services, both clinical and POCT. When 
patients heard we were providing POCT for a research project, 
patient numbers increased and further strained services.
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If POCT is to be provided for all in the massive national HIV 
programme in South Africa (~2 million HIV viral loads and ~4 
million CD4 tests performed by NHLS in 2012), and if equity is to 
prevail, POCT will need to be placed in ~3 500 clinics. The dilemma 
for POCT providers is ‘scale up or go home’. Experience with the 
National Department of Health and NHLS’s GeneXpert programme 
in 2011 showed that a phased implementation plan was required to 
manage the pace of technical and clinical training, site readiness and 
instrument installation. Even this was affected by stock-outs of kits.
So back to the road trip. We started to appreciate the enormous 
task that nurses face in caring for large numbers of patients. We 
learned to appreciate clinic workflow and that it is not just about 
turnaround time, since we showed that 72% of laboratory results were 
returned to the clinics within a day. Why then does it take weeks to 
initiate ART; and will same-day POCT really hasten this process, 
while appreciating that patient counselling, to assure acceptance and 
adherence, is also necessary?
As a laboratory scientist, I actually enjoy the clinic environment. 
I realise that POCT will require partnerships between laboratories 
and clinics. I value even more the multidisciplinary team approach to 
improving South Africa’s healthcare, especially in view of the coming 
NHI. There is much work to be done, and perhaps laboratories 
need to consider providing POCT ‘mini-labs’ to service hard-to-
reach places. Clinics could modify their workflow to decrease ART 
initiation times. Both should work on connectivity to improve 
current paper-based systems and introduce the much promised 
‘unique identifier’ to link the two.
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